Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Hematopoiesis01:21

Hematopoiesis

8.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.5K
Lineage Commitment01:21

Lineage Commitment

4.0K
Commitment is the  process whereby stem cells:
4.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced postharvest protection of cherry tomatoes by a fully bio-based quasi-mixed matrix membrane (quasi-MMM) with dual-mechanism integration of organic filler.

Food chemistry: X·2026
Same author

Multi-kingdom gut microbiota analysis identifies bacterial-viral association in multiple myeloma.

Frontiers in microbiology·2026
Same author

SLC40A1 (iron transporter): mechanistic regulation, role in disease pathogenesis, and prospects for targeted therapy.

Frontiers in cell and developmental biology·2026
Same author

Tailoring a nanozyme-based electronic tongue for coffee flavor evaluation: A rapid and accurate identification.

Food chemistry·2026
Same author

LC3B as a potential serum biomarker for screening high-risk neuroblastoma patients.

Acta neurologica Belgica·2026
Same author

Repaint High-Density Surface Electromyography Signal Using Denoising Diffusion Probabilistic Model.

IEEE transactions on bio-medical engineering·2025

Related Experiment Video

Updated: Jan 7, 2026

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging
09:10

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging

Published on: July 16, 2021

3.6K

Research progress on how mesenchymal stem cells regulate hematopoietic stem cell behavior.

YiHui Zhao1, JianXia He2

  • 1Department of Hematology, Shanxi Provincial People's Hospital, Tai Yuan, 030000, China.

Molecular Biology Reports
|December 29, 2025
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cells (MSCs) and their extracellular vesicles (EVs) are crucial for regulating hematopoietic stem cells (HSCs) in their niche. Understanding MSC-HSC interactions offers new strategies for hematopoietic stem cell transplantation (HSCT) and treating bone marrow diseases.

Keywords:
Bone marrow nicheHematopoiesisHematopoietic stem cell transplantationHematopoietic stem cellsMechanismMesenchymal stem cells

More Related Videos

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Published on: December 24, 2015

12.8K
Purification, Expansion, and Flow Cytometry-Based Phenotyping of Mouse Derived Bone Marrow Mesenchymal Stem Cells
05:10

Purification, Expansion, and Flow Cytometry-Based Phenotyping of Mouse Derived Bone Marrow Mesenchymal Stem Cells

Published on: July 11, 2025

973

Related Experiment Videos

Last Updated: Jan 7, 2026

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging
09:10

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging

Published on: July 16, 2021

3.6K
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Published on: December 24, 2015

12.8K
Purification, Expansion, and Flow Cytometry-Based Phenotyping of Mouse Derived Bone Marrow Mesenchymal Stem Cells
05:10

Purification, Expansion, and Flow Cytometry-Based Phenotyping of Mouse Derived Bone Marrow Mesenchymal Stem Cells

Published on: July 11, 2025

973

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Cell Therapy

Background:

  • Mesenchymal stem cells (MSCs) are key components of the hematopoietic stem cell (HSC) niche, influencing HSC fate.
  • MSCs are vital for HSC survival, proliferation, migration, and differentiation within the bone marrow microenvironment.
  • MSC-derived extracellular vesicles (EVs) represent a significant intercellular communication pathway regulating HSCs.

Purpose of the Study:

  • To review research progress on the mechanisms by which MSCs regulate HSCs.
  • To elucidate the role of MSC-HSC interactions in maintaining hematopoietic homeostasis.
  • To explore the potential of MSCs and EVs as adjunctive therapies for hematopoietic stem cell transplantation (HSCT).

Main Methods:

  • Literature review of studies investigating MSC-HSC interactions.
  • Analysis of intercellular communication pathways, including cell contact, soluble factors, and EVs.
  • Examination of signaling pathways and gene expression modulating MSC-HSC communication.

Main Results:

  • MSCs control HSC fate through direct contact, secreted factors, and EVs.
  • MSC-derived EVs carry bioactive molecules that influence HSC behavior.
  • Intercellular communication between MSCs and HSCs is complex, involving diverse signaling pathways.

Conclusions:

  • A deeper understanding of the MSC-HSC interaction network is essential for maintaining hematopoietic homeostasis.
  • Optimizing HSCT and developing treatments for bone marrow failure diseases can benefit from insights into MSC-HSC regulation.
  • MSCs and their EVs hold promise as therapeutic tools for HSCT and related disorders.